Physician profile
Jayson P Bell
NPI 1356508733
$6,323.88
in general payments reported to CMS, 2019-2025
11 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $254 · 2021: $1,451 · 2022: $546 · 2023: $717 · 2024: $1,364 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139 · Travel and Lodging: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,138.93 |
| Travel and Lodging | $609.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,778.37 | 2019-2025 | Pro, Pangea, Gamma |
| Orthofix Medical, INC. | $166.59 | 2019-2023 | Physio-Stim |
| Globus Medical, INC. | $123.01 | 2021-2023 | Proximal Tibia Plate |
| Ossur Americas, INC. | $66.45 | 2024-2025 | |
| Davol INC. | $45.59 | 2025 | Arista |
| Boston Scientific Corporation | $39.39 | 2025 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $32.07 | 2019 | |
| My01 INC. | $22.47 | 2022 | |
| Kerecis Limited | $19.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Molnlycke Health Care US, LLC | $19.01 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Bioventus LLC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayson Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.